Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nichols

Showing results (511-520 of 547) with videos related to

Pageof 55
Sort By:
Glia|February 23, 2008
Complex rectification of Müller cell Kir currentsYuriy V Kucheryavykh, Yaroslav M Shuba, Sergei M Antonov, et al.
The Journal of Biological Chemistry|June 2, 2024
Modulation of TMEM16B channel activity by the calcium-activated chloride channel regulator 4 (CLCA4) in human cellsMonica Sala-Rabanal, Zeynep Yurtsever, Kayla N Berry, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 26, 2015
Waterborne outbreaks in the Nordic countries, 1998 to 2012B Guzman-Herrador, A Carlander, S Ethelberg, et al.
JCI Insight|August 10, 2018
Cardiovascular consequences of KATP overactivity in Cantu syndromeYan Huang, Conor McClenaghan, Theresa M Harter, et al.
Msystems|November 9, 2016
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid MetabolismLimin Zhang, Cen Xie, Robert G Nichols, et al.
The Journal of Biological Chemistry|November 1, 2012
Self-cleavage of human CLCA1 protein by a novel internal metalloprotease domain controls calcium-activated chloride channel activationZeynep Yurtsever, Monica Sala-Rabanal, David T Randolph, et al.
Cell Metabolism|September 19, 2017
Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut MicrobiotaGuolin Li, Cen Xie, Siyu Lu, et al.
Acta Diabetologica|September 29, 2011
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live birthsD Iafusco, O Massa, B Pasquino, et al.
American Journal of Medical Genetics. Part A|June 9, 2019
Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain-of-function variant: Initial experienceAlan Ma, Sunita Gurnasinghani, Edwin P Kirk, et al.
The Journal of Clinical Investigation|December 16, 2014
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver diseaseChangtao Jiang, Cen Xie, Fei Li, et al.
Pageof 55

Showing results (511-520 of 547) with videos related to

Sort By:
Pageof 55
Glia|February 23, 2008
Complex rectification of Müller cell Kir currentsYuriy V Kucheryavykh, Yaroslav M Shuba, Sergei M Antonov, et al.
The Journal of Biological Chemistry|June 2, 2024
Modulation of TMEM16B channel activity by the calcium-activated chloride channel regulator 4 (CLCA4) in human cellsMonica Sala-Rabanal, Zeynep Yurtsever, Kayla N Berry, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 26, 2015
Waterborne outbreaks in the Nordic countries, 1998 to 2012B Guzman-Herrador, A Carlander, S Ethelberg, et al.
JCI Insight|August 10, 2018
Cardiovascular consequences of KATP overactivity in Cantu syndromeYan Huang, Conor McClenaghan, Theresa M Harter, et al.
Msystems|November 9, 2016
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid MetabolismLimin Zhang, Cen Xie, Robert G Nichols, et al.
The Journal of Biological Chemistry|November 1, 2012
Self-cleavage of human CLCA1 protein by a novel internal metalloprotease domain controls calcium-activated chloride channel activationZeynep Yurtsever, Monica Sala-Rabanal, David T Randolph, et al.
Cell Metabolism|September 19, 2017
Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut MicrobiotaGuolin Li, Cen Xie, Siyu Lu, et al.
Acta Diabetologica|September 29, 2011
Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live birthsD Iafusco, O Massa, B Pasquino, et al.
American Journal of Medical Genetics. Part A|June 9, 2019
Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain-of-function variant: Initial experienceAlan Ma, Sunita Gurnasinghani, Edwin P Kirk, et al.
The Journal of Clinical Investigation|December 16, 2014
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver diseaseChangtao Jiang, Cen Xie, Fei Li, et al.
Pageof 55